Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial. (Q42236097)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356862%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356862%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356862%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Mieke Carlier

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356862%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Alain Verstraete

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356862%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Jan J De Waele

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356862%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

S Carrette

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356862%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

V Stove

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356862%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

J Boelens

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356862%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

G Claeys

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356862%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

I Leroux-Roels

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356862%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

P Depuydt

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356862%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

J Decruyenaere

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356862%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

1 reference

20 December 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356862%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

published in

Intensive Care Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356862%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356862%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356862%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

380-387

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356862%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00134-013-3187-2

3 March 2020

exact match

0 references

cites work

International study of the prevalence and outcomes of infection in intensive care units

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Year in review in Intensive Care Medicine 2012. II: Pneumonia and infection, sepsis, coagulation, hemodynamics, cardiovascular and microcirculation, critical care organization, imaging, ethics and legal issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Clinical measures for increased creatinine clearances and suboptimal antibiotic dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Prospective determination of serum ceftazidime concentrations in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Daily serum piperacillin monitoring is advisable in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Pharmacokinetic issues for antibiotics in the critically ill patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Clinical implications of antibiotic pharmacokinetic principles in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Augmented renal clearance in the Intensive Care Unit: an illustrative case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Optimal meropenem concentrations to treat multidrug-resistant Pseudomonas aeruginosa septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Antibiotic rotation and development of gram-negative antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

How to optimise antimicrobial prescriptions in the Intensive Care Unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

A new equation to estimate glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Pharmacodynamics of cefepime in patients with Gram-negative infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Quantification of seven β-lactam antibiotics and two β-lactamase inhibitors in human plasma using a validated UPLC-MS/MS method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

ARC--augmented renal clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Case-control study of drug monitoring of β-lactams in obese critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Therapeutic drug monitoring of antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3187-2

Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients

21 January 2018

1 reference

12 December 2020

Decreased meropenem levels in Intensive Care Unit patients with augmented renal clearance: benefit of therapeutic drug monitoring

1 reference

12 December 2020

Pharmacokinetics of oseltamivir carboxylate in critically ill patients: each patient is unique

1 reference

12 December 2020

Can optimal drug dosing during ECMO improve outcomes?

1 reference

12 December 2020

Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Burns Patients—A One-Year Prospective Study

1 reference

12 December 2020

10.1007/S00134-013-3187-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356862%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference